Daniall Masood

Daniall Masood

Auto-generated profile, based on publicly available information

Daniall Masood

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDaniall Masood
Daniall Masood
MKMariia Kim
Mariia Kim
JVJeet Vora
Jeet Vora
RKRobel Kahsay
Robel Kahsay
PMPatrick McNeeley
Patrick McNeeley
RMRaja Mazumder
Raja Mazumder
Biomarkers are essential tools for disease detection, risk assessment, therapeutic monitoring, and precision medicine. However, biomarker data are dispersed across heterogeneous resources, inconsistently reported in the literature, and rarely standardized for computational use. This fragmentation limits reproducibility, cross-study integration, and the discovery of novel biomarker and disease relationships. We developed BiomarkerKB, a knowledgebase designed to harmonize and integrate biomarker information under a standardized data model. The model follows the FDA-NIH BEST biomarker definition and captures both core fields (biomarker entity, disease/condition, exposure agent) and contextual metadata (specimen, biomarker role, evidence, provenance). Biomarker data and related annotations were either curated from publications or collected from public resources (e.g., OpenTargets, GWAS Catalog, ClinVar, CIViC, OncoMX) and were also contributed by the Common Fund Data Coordinating Centers and the Early Detection Research Network (EDRN). Standardization was achieved using ontologies and reference resources such as Disease Ontology, UBERON, UniProtKB, and HUGO Gene Nomenclature Committee (HGNC) gene symbols. BiomarkerKB data were ingested into a Neo4j-based knowledge graph and integrated with the Common Fund Data Ecosystem (CFDE) Knowledge Graph. The initial release of BiomarkerKB contains over 200,000 biomarker-disease associations spanning genes, proteins, metabolites, glycans, and chemical elements. The knowledge graph comprises more than 300,000 nodes and 1.2 million edges, enabling structured exploration of biomarker relationships within CFDE data as demonstrated through the knowledge graph query-based use cases presented in this study. A publicly accessible web portal ( https://biomarkerkb.org ) provides keyword search, filtering, data downloads, and access to graph visualization to support both researchers and computational analyses. BiomarkerKB addresses a critical gap in biomarker informatics by providing an integrated, FAIR (Findable, Accessible, Interoperable, and Reusable), and unified framework for biomarker knowledge exploration and discovery.

26 November 2025 in BioHackrXiv
Verified
Preprint
Open access
MPMina P. Peyton
Mina P. Peyton
CCCheng-Han Chung
Cheng-Han Chung
SMSamarpan Mohanty
Samarpan Mohanty
VTVan Q. Truong
Van Q. Truong
ASAndrew Scouten
Andrew Scouten
BBBen Busby
Ben Busby
Knowledge graphs (KGs) and large language models (LLMs) are increasingly applied in biomedical research; however, LLMs' tendency to hallucinate and lack of evidence traceability poses significant challenges for rigorous scientific applications. To address these limitations, the NVIDIA - AWS Open Data Knowledge Graph Hackathon, which brought together transatlantic teams, catalyzed the development of novel frameworks that built or integrated KGs with graph-based retrieval-augmented generation (GraphRAG) to enhance evidence-grounded generative AI. The hackathon took place on October 1-3, 2025, at two locations - the AWS Skills Center in Arlington, VA, USA and the European Bioinformatics Institute (EBI) Training Center in Cambridge, UK. Across seven prototype projects, participating teams developed systems that construct, validate, and deploy biomedical KGs using open data and cloud-native infrastructure. These included GeNETwork, which integrates pediatric oncology datasets to identify therapeutic targets; ECoGraph, a multi-omics graph framework for characterizing colorectal cancer drivers; ClassiGraph, a graph neural network classifier for cancer subtypes; EasyGiraffe, a validator for multisite polygenicity extraction; MIDAS (Model Integration and Data Assembly System), a pipeline for harmonizing heterogeneous biomedical datasets; KG Model Garbage Collection, a framework for detecting and pruning erroneous AI-generated edges; and BioGraphRAG, which combines precision medicine and literature-derived KGs for evidence-based question answering. Together, these prototypes demonstrate practical strategies for constructing and deploying biomedical KGs and highlight the potential of GraphRAG to produce interpretable, verifiable AI-driven insights. By emphasizing open data, reproducible pipelines, and evidence-grounded reasoning, this work advances methodologies for trustworthy generative AI in biomedical discovery.